ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633275 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633275; 2) Community: the network communities that were significantly associated with the response to NSC 633275; 3) Molecule: the relationships between components within communities and NSC 633275; 4) MDR: the compounds that were significantly associated with the NSC 633275.

NSC Compound Enrichment Correlation
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.0329129886465387 0.18125562
NSC 143093 Acetylkidamycin 0.0329129886465389 0.32565863
NSC 187546 Ethanimidamide, 2-chloro-N-(tricyclo[3.3.1.1(3,7)]dec-1-ylmethyl)-, monohydrochloride 0.0329129886465389 0.33116745
NSC 266046 Oxaliplatin 0.0329129886465389 0.43370041
NSC 281279 Platinum, aqua(1,2-cyclohexanediamine-N,N')(tetraoxoselenato(2-)-O)-, (SP-4-3)- 0.0329129886465389 0.24167391
NSC 325268 Null 0.0329129886465389 0.25124467
NSC 329515 Kijanimicin sodium salt 0.0329129886465389 0.30128541
NSC 36525 8-[(4-tert-butylphenoxy)methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione 0.0329129886465389 0.31747631
NSC 377852 Null 0.0329129886465389 0.45748287
NSC 405159 2,5-Cyclohexadiene-.delta.1,.alpha.-acetonitrile, 4-oxo-.alpha.-phenyl-, oxime 0.0329129886465389 0.30822676
Total:113  Current:85    [First] [Prev] [Next] [Last]